Recap: WAVE Life Sciences Q1 Earnings
WAVE Life Sciences (NASDAQ:WVE) reported its Q1 earnings results on Thursday, May 12, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Wave Life Sciences Announces Publication Of Foundational Preclinical Data Supporting Development Of WVE-004 For C9orf72-Associated ALS and FTD
Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the publication of
Wave Life Sciences Jump As Low Doses of WVE-004 Lowers Disease Biomarker In Neurological Indications
Wave Life Sciences Ltd's (NASDAQ: WVE)
Wave Life Sciences Announces Update To Ongoing Phase 1b/2a FOCUS-C9 Study Driven By Potent, Durable Reductions Of Poly(GP) With Low, Single Doses Of WVE-004
Reductions in poly(GP), a key disease biomarker indicating target engagement, observed across all treatment groups after single doses
Extending dose observation period from three months (day 85) to six months to
Wave Life Sciences Announces Nature Biotechnology Publication Highlighting First RNA Base Editing In Non-human Primates Using An Endogenous Enzyme
Wave Life Sciences Ltd. (NASDAQ:WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced the publication of preclinical
Earnings Scheduled For March 3, 2022
Companies Reporting Before The Bell
• Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.